Your browser doesn't support javascript.
loading
SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma.
OuYang, Li-Ying; Deng, Zi-Jian; You, Yu-Feng; Fang, Jia-Ming; Chen, Xi-Jie; Liu, Jun-Jie; Li, Xian-Zhe; Lian, Lei; Chen, Shi.
  • OuYang LY; Department of Intensive Care Unit, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Deng ZJ; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • You YF; Guangdong Institute of Gastroenterology, Guangzhou, China.
  • Fang JM; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangzhou, China.
  • Chen XJ; School of Medicine, Sun Yat-Sen University, Guangzhou, China.
  • Liu JJ; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Li XZ; Guangdong Institute of Gastroenterology, Guangzhou, China.
  • Lian L; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangzhou, China.
  • Chen S; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Front Immunol ; 13: 977894, 2022.
Article en En | MEDLINE | ID: mdl-36052090
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article